Let’s dive into patent protections. AbbVie ($169.B market cap) just won a lawsuit in favor of its “patent-aggressive US strategy” for the world’s best selling drug, Humira, which treats diseases like
Share this post
Visible Hands: 💊 In Sickness and In Wealth
Share this post
Let’s dive into patent protections. AbbVie ($169.B market cap) just won a lawsuit in favor of its “patent-aggressive US strategy” for the world’s best selling drug, Humira, which treats diseases like